362 related articles for article (PubMed ID: 28780190)
1. Targeting Eph/ephrin system in cancer therapy.
Lodola A; Giorgio C; Incerti M; Zanotti I; Tognolini M
Eur J Med Chem; 2017 Dec; 142():152-162. PubMed ID: 28780190
[TBL] [Abstract][Full Text] [Related]
2. Editorial: Small Molecules and Peptides Targeting the Eph-Ephrin System.
Tognolini M; Lodola A
Curr Drug Targets; 2015; 16(10):1020. PubMed ID: 26435471
[No Abstract] [Full Text] [Related]
3. Eph/Ephrin Signaling in the Tumor Microenvironment.
Ieguchi K; Maru Y
Adv Exp Med Biol; 2021; 1270():45-56. PubMed ID: 33123992
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of targeting the Eph/ephrin signaling complex.
Saha N; Robev D; Mason EO; Himanen JP; Nikolov DB
Int J Biochem Cell Biol; 2018 Dec; 105():123-133. PubMed ID: 30343150
[TBL] [Abstract][Full Text] [Related]
5. Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond.
Lamminmaki U; Nikolov D; Himanen J
Curr Drug Targets; 2015; 16(10):1021-30. PubMed ID: 26028047
[TBL] [Abstract][Full Text] [Related]
6. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
7. Eph receptors and ephrins: therapeutic opportunities.
Barquilla A; Pasquale EB
Annu Rev Pharmacol Toxicol; 2015; 55():465-87. PubMed ID: 25292427
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Eph System with Peptides and Peptide Conjugates.
Riedl SJ; Pasquale EB
Curr Drug Targets; 2015; 16(10):1031-47. PubMed ID: 26212263
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors.
Tognolini M; Lodola A
Curr Drug Targets; 2015; 16(10):1048-56. PubMed ID: 26302794
[TBL] [Abstract][Full Text] [Related]
10. Ephrin or not? Six tough questions on Eph targeting.
Giorgio C; Zanotti I; Lodola A; Tognolini M
Expert Opin Ther Targets; 2020 May; 24(5):403-415. PubMed ID: 32197575
[No Abstract] [Full Text] [Related]
11. Eph receptors and ephrins as targets for cancer therapy.
Xi HQ; Wu XS; Wei B; Chen L
J Cell Mol Med; 2012 Dec; 16(12):2894-909. PubMed ID: 22862837
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.
Noberini R; Koolpe M; Lamberto I; Pasquale EB
Pharmacol Res; 2012 Oct; 66(4):363-73. PubMed ID: 22750215
[TBL] [Abstract][Full Text] [Related]
13. Eph receptor tyrosine kinases in cancer stem cells.
Chen J; Song W; Amato K
Cytokine Growth Factor Rev; 2015 Feb; 26(1):1-6. PubMed ID: 24933439
[TBL] [Abstract][Full Text] [Related]
14. Eph as a target in inflammation.
Ieguchi K
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):119-28. PubMed ID: 25772170
[TBL] [Abstract][Full Text] [Related]
15. Eph-ephrin bidirectional signaling in physiology and disease.
Pasquale EB
Cell; 2008 Apr; 133(1):38-52. PubMed ID: 18394988
[TBL] [Abstract][Full Text] [Related]
16. The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.
Kandouz M
Cancer Metastasis Rev; 2012 Jun; 31(1-2):353-73. PubMed ID: 22549394
[TBL] [Abstract][Full Text] [Related]
17. Targeting Eph receptors with peptides and small molecules: progress and challenges.
Noberini R; Lamberto I; Pasquale EB
Semin Cell Dev Biol; 2012 Feb; 23(1):51-7. PubMed ID: 22044885
[TBL] [Abstract][Full Text] [Related]
18. [Eph family receptors as therapeutic targets].
Zozulya SA; Udovichenko IP
Bioorg Khim; 2012; 38(3):267-79. PubMed ID: 22997698
[TBL] [Abstract][Full Text] [Related]
19. Eph-ephrin signalling in adult tissues and cancer.
Merlos-Suárez A; Batlle E
Curr Opin Cell Biol; 2008 Apr; 20(2):194-200. PubMed ID: 18353626
[TBL] [Abstract][Full Text] [Related]
20. Ephrin expression and function in cancer.
McCarron JK; Stringer BW; Day BW; Boyd AW
Future Oncol; 2010 Jan; 6(1):165-76. PubMed ID: 20021216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
